Pathnova
Singapore, Singapore· Est.
AI‑enabled, automated IFA diagnostics for NPC and EBV, delivering lab‑grade accuracy at scale.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑enabled, automated IFA diagnostics for NPC and EBV, delivering lab‑grade accuracy at scale.
OncologyInfectious Disease
Technology Platform
AI‑powered image analysis combining deep learning with fuzzy inference to automate and quantify immunofluorescence assay results.
Opportunities
Scaling AI‑driven IFA diagnostics across additional virus‑associated cancers and autoimmune diseases, and expanding into regional and global regulatory markets.
Risk Factors
Regulatory approval timelines, data privacy and algorithmic validation, and competition from larger IVD and AI pathology firms.
Competitive Landscape
Competes with traditional IVD manufacturers and AI pathology platforms such as PathAI and Paige, differentiating through a highly interpretable fuzzy‑inference model and region‑specific NPC expertise.